NCT03340506 2026-02-03Dabrafenib and/or Trametinib Rollover StudyNovartisPhase 4 Recruiting100 enrolled
NCT06712875 2025-05-29MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric GliomasAnn & Robert H Lurie Children's Hospital of ChicagoPhase 1/2 Recruiting27 enrolled